Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Rash and fever in a kidney transplant recipient.

Todd PJ, Smyth JS, Leonard N, McCaughan JA.

Am J Transplant. 2020 Mar;20(3):898-900. doi: 10.1111/ajt.15683. No abstract available.

PMID:
32090471
2.

Reclassification of CLSI criteria for ciprofloxacin and levofloxacin susceptibility against Pseudomonas aeruginosa: Implications for patients with cystic fibrosis (CF).

Millar BC, Malnarcic CM, McCaughan J, Moore JE.

Clin Respir J. 2020 Jan;14(1):64-68. doi: 10.1111/crj.13100. Epub 2019 Nov 14. No abstract available.

PMID:
31663261
3.

Improved culture detection of Staphylococcus aureus from sputum of patients with cystic fibrosis (CF).

Wen H, Stirling J, McCaughan J, Schock B, Downey DG, Ennis M, Moore JE.

J Clin Pathol. 2019 Dec;72(12):837-838. doi: 10.1136/jclinpath-2019-206059. Epub 2019 Oct 13. No abstract available.

PMID:
31611286
4.

Gene expression profiling and racial disparities in outcomes after heart transplantation.

Moayedi Y, Fan CS, Miller RJH, Tremblay-Gravel M, Posada JGD, Manlhiot C, Hiller D, Yee J, Woodward R, McCaughan JA, Shullo MA, Hall SA, Pinney S, Khush KK, Ross HJ, Teuteberg JJ.

J Heart Lung Transplant. 2019 Aug;38(8):820-829. doi: 10.1016/j.healun.2019.05.008. Epub 2019 May 24.

PMID:
31201087
5.

Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff.

McCaughan J, Xu Q, Tinckam K.

Hepatobiliary Surg Nutr. 2019 Feb;8(1):37-52. doi: 10.21037/hbsn.2019.01.01. Review.

6.
7.

Snow angels - the microbiology of freshly fallen snow: implications for immunocompromised patients.

Moore JE, McCaughan J, Stirling J, Bell J, Millar BC.

J Water Health. 2018 Dec;16(6):1029-1032. doi: 10.2166/wh.2018.156.

PMID:
30540276
8.

De novo donor-specific HLA antibodies in heart transplantation: Do transient de novo DSA confer the same risk as persistent de novo DSA?

Moayedi Y, Fan CS, Tinckam KJ, Ross HJ, McCaughan JA.

Clin Transplant. 2018 Nov;32(11):e13416. doi: 10.1111/ctr.13416. Epub 2018 Oct 22.

PMID:
30276870
9.

Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management.

McCaughan JA, Tinckam KJ.

Transpl Int. 2018 Oct;31(10):1059-1070. doi: 10.1111/tri.13324. Review.

10.

"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.

Gilligan PH, Downey DG, Elborn JS, Flume PA, Funk S, Gilpin D, Kidd TJ, McCaughan J, Millar BC, Murphy PG, Rendall JC, Tunney MM, Moore JE.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00193-18. doi: 10.1128/JCM.00193-18. Print 2018 Sep.

11.

INCREASING BURDEN OF ANTIMICROBIAL RESISTANCE IN PSEUDOMONAS AERUGINOSA FROM ADULT PATIENTS WITH CYSTIC FIBROSIS (CF) IN NORTHERN IRELAND: THEN AND NOW.

Gramegna A, Moore JE, McCaughan J, Millar BC, Ewing J, Elborn JS, Blasi F, Downey DG.

Ulster Med J. 2018 May;87(2):129-130. Epub 2018 May 30. No abstract available.

12.

Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantation.

McCaughan JA, Battle RK, Singh SKS, Tikkanen JM, Moayedi Y, Ross HJ, Singer LG, Keshavjee S, Tinckam KJ.

Am J Transplant. 2018 Dec;18(12):2924-2933. doi: 10.1111/ajt.14951. Epub 2018 Jun 22.

13.

Belfast Agar-a simple laboratory medium to separate Pseudomonas aeruginosa from pan-resistant Burkholderia cenocepacia isolated from the sputum of patients with cystic fibrosis (CF).

Caskey S, Moore JE, McCaughan J, Rendall JC.

Br J Biomed Sci. 2018 Apr;75(2):101-103. doi: 10.1080/09674845.2017.1411018. Epub 2018 Mar 7. No abstract available.

PMID:
29513134
14.

Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis.

O'Neill K, Bradley JM, Reid A, Downey DG, Rendall J, McCaughan J, Moore JE, Tunney MM, Elborn JS.

Eur Respir J. 2018 Jan 31;51(2). pii: 1701704. doi: 10.1183/13993003.01704-2017. Print 2018 Feb. No abstract available.

15.

Muddy puddles - the microbiology of puddles located outside tertiary university teaching hospitals.

Furukawa M, McCaughan J, Stirling J, Millar BC, Bell J, Goldsmith CE, Reid A, Misawa N, Moore JE.

Lett Appl Microbiol. 2018 Apr;66(4):284-292. doi: 10.1111/lam.12856. Epub 2018 Feb 23.

PMID:
29377174
16.

Is big bad or bearable? Long-term renal transplant outcomes in obese recipients.

McCloskey OM, Devine PA, Courtney AE, McCaughan JA.

QJM. 2018 Jun 1;111(6):365-371. doi: 10.1093/qjmed/hcx258.

PMID:
29329414
17.

Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.

Millar BC, McCaughan J, Rendall JC, Downey DG, Moore JE.

J Clin Pharm Ther. 2018 Feb;43(1):92-100. doi: 10.1111/jcpt.12616. Epub 2017 Sep 22.

PMID:
29293275
18.

Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His.

Shteinberg M, Downey DG, Beattie D, McCaughan J, Reid A, Stein N, Elborn JS.

ERJ Open Res. 2017 Mar 31;3(1). pii: 00056-2016. doi: 10.1183/23120541.00056-2016. eCollection 2017 Jan.

19.

Relative resistance index (RRI) - a scoring system for antibiotic resistance in Pseudomonas aeruginosa.

Ewing J, McCaughan J, Moore J, Fairley D, Sutherland B, Reid A, Downey D.

Br J Biomed Sci. 2017 Oct;74(4):198-202. doi: 10.1080/09674845.2017.1338500. Epub 2017 Jul 26.

PMID:
28745144
20.

Successful kidney transplantation in highly sensitized, ultra-long-term dialysis patients.

McCaughan JA, Courtney AE.

Transpl Int. 2017 Aug;30(8):844-846. doi: 10.1111/tri.12970. Epub 2017 Jun 2. No abstract available.

21.

Preformed donor-specific HLA antibodies are associated with increased risk of early mortality after liver transplantation.

McCaughan JA, Robertson V, Falconer SJ, Cryer C, Turner DM, Oniscu GC.

Clin Transplant. 2016 Dec;30(12):1538-1544. doi: 10.1111/ctr.12851. Epub 2016 Oct 20.

PMID:
27653177
22.

MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis.

Vallières E, Rendall JC, Moore JE, McCaughan J, Hoeritzauer AI, Tunney MM, Elborn JS, Downey DG.

ERJ Open Res. 2016 Mar 15;2(1). pii: 00064-2015. eCollection 2016 Jan.

23.

Electrostatic Potential Change in a Paired Epitope: A Novel Explanation for Bw4 Antibodies in Patients With B13 (Bw4) Antigens.

McCaughan JA, Turner DM, Battle RK.

Transplantation. 2016 Jul;100(7):e32-4. doi: 10.1097/TP.0000000000001193. No abstract available.

PMID:
27326812
24.

Synthesis and Characterisation of Substrate-Based Peptides as Inhibitors of Histone Demethylase KDM4C.

Nielsen SD, Leurs U, Bergner M, Barris SA, Devkota K, Meyer K, Iaria D, McCaughan J, Lohse B, Kristensen JL, Clausen RP.

Protein Pept Lett. 2016;23(9):772-6.

PMID:
27295953
25.

Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.

OʼRegan JA, Prendeville S, McCaughan JA, Traynor C, OʼBrien FJ, Ward FL, OʼDonovan D, Kennedy C, Berzan E, Kinsella S, Williams Y, OʼKelly P, Deady S, Comber H, Leader M, Conlon PJ.

Transplantation. 2017 Mar;101(3):657-663. doi: 10.1097/TP.0000000000001201.

PMID:
27214265
26.

Analysis of single nucleotide polymorphisms implicate mTOR signalling in the development of new-onset diabetes after transplantation.

Chand S, McKnight AJ, Shabir S, Chan W, McCaughan JA, Maxwell AP, Harper L, Borrows R.

BBA Clin. 2016 Jan 8;5:41-5. doi: 10.1016/j.bbacli.2015.12.004. eCollection 2016 Jun.

27.

How reliable are cough swabs for the detection of Pseudomonas aeruginosa in adult patients with cystic fibrosis?

Moore JE, McCaughan J, McNeilly J, Rendall JC, Downey DG.

Br J Biomed Sci. 2015;72(4):206. No abstract available.

PMID:
26738405
28.

Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis.

Hill CJ, Courtney AE, Cardwell CR, Maxwell AP, Lucarelli G, Veroux M, Furriel F, Cannon RM, Hoogeveen EK, Doshi M, McCaughan JA.

Nephrol Dial Transplant. 2015 Aug;30(8):1403-11. doi: 10.1093/ndt/gfv214. Epub 2015 Jun 4. Review.

PMID:
26044837
29.

The clinical course of kidney transplant recipients after 20 years of graft function.

McCaughan JA, Courtney AE.

Am J Transplant. 2015 Mar;15(3):734-40. doi: 10.1111/ajt.13041. Epub 2015 Feb 12.

30.

Factors influencing survival after kidney transplant failure.

McCaughan JA, Patterson CC, Maxwell AP, Courtney AE.

Transplant Res. 2014 Sep 24;3:18. doi: 10.1186/2047-1440-3-18. eCollection 2014.

31.

Do veterinary antibiotics have efficacy against highly resistant Gram-negative pathogens from patients with cystic fibrosis?

Moore JE, Alcorn M, Ara W, Millar BC, McCaughan J, Rendall JC, McNeilly J, Kuribayashi T, Yamamoto S, Matsuda M, Goldsmith CE, Elborn JS, Downey DG.

Int J Antimicrob Agents. 2015 Jan;45(1):93-5. doi: 10.1016/j.ijantimicag.2014.08.003. Epub 2014 Sep 6. No abstract available.

PMID:
25245210
32.

β cell glucotoxic-associated single nucleotide polymorphisms in impaired glucose tolerance and new-onset diabetes after transplantation.

Chand S, Shabir S, Chan W, McCaughan JA, McKnight AJ, Maxwell AP, Borrows R.

Transplantation. 2014 Aug 15;98(3):e19-20. doi: 10.1097/TP.0000000000000268. No abstract available.

PMID:
25089340
33.

Surveillance of nonmelanoma skin cancer incidence rates in kidney transplant recipients in Ireland.

Bannon FJ, McCaughan JA, Traynor C, O'Brien K, Gavin AT, Maxwell AP, Comber H, Conlon PJ.

Transplantation. 2014 Sep 27;98(6):646-52. doi: 10.1097/TP.0000000000000115.

PMID:
24798309
34.

Estimated glomerular filtration rate decline as a predictor of dialysis in kidney transplant recipients.

McCaughan JA, Courtney AE, Maxwell AP.

Am J Nephrol. 2014;39(4):297-305. doi: 10.1159/000360426. Epub 2014 Apr 10.

PMID:
24732139
35.

Do patients with chronic kidney disease get optimal cardiovascular risk reduction?

Elliott MK, McCaughan JA, Fogarty DG.

Curr Opin Nephrol Hypertens. 2014 May;23(3):267-74. doi: 10.1097/01.mnh.0000444913.78536.b1. Review.

PMID:
24694581
36.

Genetics of new-onset diabetes after transplantation.

McCaughan JA, McKnight AJ, Maxwell AP.

J Am Soc Nephrol. 2014 May;25(5):1037-49. doi: 10.1681/ASN.2013040383. Epub 2013 Dec 5.

37.

Comprehensive investigation of the caveolin 2 gene: resequencing and association for kidney transplant outcomes.

McCaughan JA, Duffy S, O'Hagan T, Courtney AE, Borrows R, Conlon PJ, Maxwell AP, McKnight AJ.

PLoS One. 2013 May 7;8(5):e63358. doi: 10.1371/journal.pone.0063358. Print 2013.

38.

The complement cascade in kidney disease: from sideline to center stage.

McCaughan JA, O'Rourke DM, Courtney AE.

Am J Kidney Dis. 2013 Sep;62(3):604-14. doi: 10.1053/j.ajkd.2012.12.033. Epub 2013 Mar 13. Review.

PMID:
23489674
39.

Epigenetics: time to translate into transplantation.

McCaughan JA, McKnight AJ, Courtney AE, Maxwell AP.

Transplantation. 2012 Jul 15;94(1):1-7. doi: 10.1097/TP.0b013e31824db9bd. Review.

PMID:
22437848
40.

Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients.

Rao P, McCaughan J, McCalmont M, Goldsmith CE, Hall V, Millar BC, McCann MA, Downey DG, Rendall JC, Elborn JS, Moore JE.

J Cyst Fibros. 2012 Jul;11(4):349-52. doi: 10.1016/j.jcf.2012.01.002. Epub 2012 Feb 9. No abstract available.

41.

Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies.

McCaughan JA, O'Rourke DM, Courtney AE.

Am J Transplant. 2012 Apr;12(4):1046-51. doi: 10.1111/j.1600-6143.2011.03923.x. Epub 2012 Jan 10.

42.

Acute Kidney Injury: It's as easy as ABCDE.

Forde C, McCaughan J, Leonard N.

BMJ Qual Improv Rep. 2012 Dec 18;1(1). pii: u200370.w326. doi: 10.1136/bmjquality.u200370.w326. eCollection 2012.

43.

Pneumocystis jiroveci pneumonia in renal transplantation: time to review our practice?

McCaughan JA, Courtney AE.

Nephrol Dial Transplant. 2012 Jan;27(1):13-5. doi: 10.1093/ndt/gfr444. Epub 2011 Aug 3. No abstract available.

PMID:
21813831
44.

Managing patients on dialysis in the community.

McCaughan JA, Courtney AE.

Practitioner. 2011 Feb;255(1737):19-22, 2-3.

PMID:
21539144
45.

Molecular conservation within LES9F and PS21 liverpool epidemic strain (LES) markers in wild-type clinical pseudomonas aeruginosa isolated from the sputum of adult patients with cystic fibrosis.

Kakinuma Y, Goldsmith CE, Watt A, Elborn JS, Maeda Y, Rendall JC, Hall V, McCaughan J, Reid A, Millar BC, Matsuda M, Moore JE.

Br J Biomed Sci. 2010;67(2):87-8. No abstract available.

PMID:
20669766
46.

Embolisation of vegetation to the liver in right sided infective endocarditis.

McCaughan JA, Purvis JA, Sharkey RA.

Eur J Intern Med. 2009 Mar;20(2):e32-3. doi: 10.1016/j.ejim.2008.08.008. Epub 2008 Oct 1. No abstract available.

PMID:
19327593
47.

Photodynamic therapy for obstructive esophageal malignancies.

McCaughan JS.

Diagn Ther Endosc. 1999;5(3):167-74. doi: 10.1155/DTE.5.167.

48.

Predictors of mortality in adults with cystic fibrosis.

Courtney JM, Bradley J, Mccaughan J, O'Connor TM, Shortt C, Bredin CP, Bradbury I, Elborn JS.

Pediatr Pulmonol. 2007 Jun;42(6):525-32.

PMID:
17469153
49.
50.

Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol.

Macfarlane M, Leavy A, McCaughan J, Fair R, Reid AJ.

J Hosp Infect. 2007 Mar;65(3):231-6. Epub 2006 Dec 18.

PMID:
17178427

Supplemental Content

Loading ...
Support Center